3049 - 3060 of 7695 results
woman blowing her nose with cup of tea
2.5 CME CREDITS

Populations at High Risk for Influenza: CDC and IDSA Recommendations

Podcast 1

0.25 CME/MOC
0.38 AANP | 0.43 Pharmacology

This brief podcast will answer your most salient questions about managing influenza in high-risk patients, starting with how to identify those patients and determine their risk for developing complications. Next, you will listen to the experts discuss the latest CDC and IDSA recommendations for preventing influenza—including the use of post-exposure prophylaxis—in this vulnerable patient population. Finally, you will hear the recommendations for testing for influenza—within the context of the COVID-19 pandemic—and treating patients with influenza at high risk for complications.


0.25 CME CREDIT

What’s New in Influenza Management? (Module 4)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.25 AANP | 0.07 Pharmacology

Are you aware of the recent updates in the prevention, testing, and treatment of influenza? This brief module arms you with the most important updates you’ll need to protect your patients in this upcoming influenza season. You’ll hear about the newly available quadrivalent high-dose influenza vaccine and the recently FDA-approved therapy that could potentially improve efficacy and treatment adherence while reducing transmission of influenza. You’ll also walk away with proven approaches to testing patients with acute respiratory illness—hint: it depends on what’s circulating in the community. Before you see your next patient, read through this innovative infographic that is enhanced with audio clips, questions, and additional references to enhance your learning and keep you engaged.


Senior man swallowing pill
0.5 CME CREDIT

What PCPs Need to Know About Influenza Treatment (Module 2)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.20 Pharmacology

In recent years, a new first-in-class antiviral emerged that expanded the arsenal of effective treatments for influenza. But do you know when to prescribe these therapies and which ones are most appropriate for each individual patient? Research has shown that only a fraction of patients at severe risk for influenza-related complications receive an antiviral medication within the appropriate timeframe of symptom onset. Before you see your next patient with influenza, you need to participate in this short and innovative video-based activity that is designed to enhance learning and keep you engaged. You will walk away with guideline-recommended strategies to appropriately initiate antiviral treatment for known or suspected influenza.